Entities / Company
Ensysce Biosciences.
company in La Jolla, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 24
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
Enveric Biosciences, Inc. trades on the Nasdaq stock exchange.Some support4 reports
-
The FDA has provided positive feedback regarding the PF614-MPAR development, acknowledging safety benefits and collaborative efforts.Some support9 reports
-
A research firm released an update on Ensysce Biosciences, noting the company received a $5.3 million installment for a platform study conducted in collaboration with a CRO.Some support1 report1 development inside
-
Ensysce Biosciences announced that on July 16, 2025, Rho, Inc. was selected as their clinical research partner.Some support1 report
-
Brad Sorensen published a research report on Ensysce Biosciences' efforts to develop pain relief for the American public.Some support1 report
-
Geoff Birkett has been appointed Chief Commercial Officer of Ensysce Biosciences, and he began his career in Newcastle.Some support1 report
-
Ensysce Biosciences hosted a symposium in Las Vegas, featuring Chief Medical Officer William Schmidt.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Ensysce Biosciences this week
News at the entities that move Ensysce Biosciences most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Ensysce Biosciences
-
Nasdaq Shared contextApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Ensysce Biosciences
-
La Jolla Shared contextAlicia Keys is reportedly working on a musical project based on the book of Kristoffer Diaz, while she maintains a residence in the La Jolla neighborhood.Moves Ensysce Biosciences
-
California Shared contextPolitical challenges are facing Greenland, while an AI pilot tests care decisions for older adults, alongside a new solar energy offering for homeowners.Moves Ensysce Biosciences
Connections
The 7 strongest of 24, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
William Schmidt Structural
William Schmidt serves as the Chief Medical Officer of Ensysce Biosciences.
-
National Institute on Drug Abuse Structural
NIDA provides grant funding to Ensysce Biosciences to accelerate clinical development programs.
-
FDA Structural
Ensysce Biosciences relies on the FDA for regulatory guidance, feedback, and designation of its product development.
-
Nasdaq Shared context
A is a company whose stock is listed and traded on the Nasdaq exchange.
-
La Jolla Shared context
Ensysce Biosciences is factually headquartered in the La Jolla neighborhood.
-
California Shared context
The company operates within the context of the state, sharing a geographic and regulatory backdrop.
-
National Institute of Dramatic Art Mentioned together
No verifiable relationship between the two entities was found in the provided evidence.
History
Events by the month they beganJune 2026
8 events- Ensysce Biosciences is developing novel opioid candidates, including PF614, aimed at treating pain and addressing the opioid addiction epidemic.
- Enveric Biosciences, Inc. trades on the Nasdaq stock exchange.
- The FDA has provided positive feedback regarding the PF614-MPAR development, acknowledging safety benefits and collaborative efforts.
- A research firm released an update on Ensysce Biosciences, noting the company received a $5.3 million installment for a platform study conducted in collaboration with a CRO.
- Ensysce Biosciences announced that on July 16, 2025, Rho, Inc. was selected as their clinical research partner.
- Brad Sorensen published a research report on Ensysce Biosciences' efforts to develop pain relief for the American public.
- Geoff Birkett has been appointed Chief Commercial Officer of Ensysce Biosciences, and he began his career in Newcastle.
- Ensysce Biosciences hosted a symposium in Las Vegas, featuring Chief Medical Officer William Schmidt.